Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of an autoinhibitory, mitophagy-inducing peptide derived from the transmembrane domain of USP30
Xuan Qin, Rui Wang, Hongkun Xu, et al.
Autophagy (2022) Vol. 18, Iss. 9, pp. 2178-2197
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 151
Ameliorating Mitochondrial Dysfunction of Neurons by Biomimetic Targeting Nanoparticles Mediated Mitochondrial Biogenesis to Boost the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Hao Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 45
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Single-Atom Nanocatalytic Therapy for Suppression of Neuroinflammation by Inducing Autophagy of Abnormal Mitochondria
Bowen Li, Yang Bai, Yion Chan, et al.
ACS Nano (2023) Vol. 17, Iss. 8, pp. 7511-7529
Closed Access | Times Cited: 35
Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
Xiang Li, Qian Liu, Xin Xie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1700-1711
Closed Access | Times Cited: 23
Mechanism and role of mitophagy in the development of severe infection
Lixiu Ma, Tianyu Han, Y M Zhan
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Traceless Peptide and Protein Modification via Rational Tuning of Pyridiniums
Chuan Wan, Yichi Zhang, Jinpeng Wang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 4, pp. 2624-2633
Closed Access | Times Cited: 9
Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders
Guangming Zhang, Huayuan Wei, Anliu Zhao, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
The expanding repertoire of covalent warheads for drug discovery
Namrashee V. Mehta, Mariam S. Degani
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103799-103799
Closed Access | Times Cited: 20
Therapeutic targeting of mitophagy in Parkinson's disease
Shashank Masaldan, Sylvie Callegari, Grant Dewson
Biochemical Society Transactions (2022) Vol. 50, Iss. 2, pp. 783-797
Open Access | Times Cited: 27
Chemical mitophagy modulators: Drug development strategies and novel regulatory mechanisms
Dong Yu, Xu‐Xu Zhuang, Yi‐Ting Wang, et al.
Pharmacological Research (2023) Vol. 194, pp. 106835-106835
Open Access | Times Cited: 15
Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects
Shuixia Tan, Da Wang, Yuhua Fu, et al.
Science Bulletin (2023) Vol. 68, Iss. 23, pp. 3013-3026
Open Access | Times Cited: 15
Targeting mitochondrial degradation by chimeric autophagy-tethering compounds
Zhenqi Liu, Geng Qin, Jie Yang, et al.
Chemical Science (2023) Vol. 14, Iss. 40, pp. 11192-11202
Open Access | Times Cited: 14
Molecular Symphony of Mitophagy: Ubiquitin‐Specific Protease‐30 as a Maestro for Precision Management of Neurodegenerative Diseases
Ankit Siwach, Harit Patel, Amit Khairnar, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access
Targeted Degradation Technology Based on the Autophagy‐Lysosomal Pathway: A Promising Strategy for Treating Preeclampsia
Lin Xiao, Mei Zhang, Jing Chen, et al.
American Journal of Reproductive Immunology (2025) Vol. 93, Iss. 3
Closed Access
Met-Exo attenuates pyroptosis in miniature pig liver IRI by improving mitochondrial quality control
Lei Cao, P. Andy Li, Tao Liu, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114437-114437
Closed Access
Improving mitochondria-associated endoplasmic reticulum membranes integrity as converging therapeutic strategy for rare neurodegenerative diseases and cancer
Michal Cagalinec, Mohd Adnan, Silvia Borecká, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119954-119954
Closed Access
Activation of ULK1 to trigger FUNDC1-mediated mitophagy in heart failure: Effect of Ginsenoside Rg3 intervention
Xiaoping Wang, Guanjing Ling, Wei Yan, et al.
Phytomedicine (2023) Vol. 120, pp. 155042-155042
Closed Access | Times Cited: 11
Inhibition of USP30 Promotes Mitophagy by Regulating Ubiquitination of MFN2 by Parkin to Attenuate Early Brain Injury After SAH
Yang Liu, Chenbei Yao, Bin Sheng, et al.
Translational Stroke Research (2023)
Open Access | Times Cited: 11
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
Low-Toxicity Sulfonium-Based Probes for Cysteine-Specific Profiling in Live Cells
Rui Wang, Dongyan Yang, Tian Tian, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 10, pp. 4366-4372
Closed Access | Times Cited: 17
Targeting of HBP1/TIMP3 axis as a novel strategy against breast cancer
Yue Zhou, Tongjia Zhang, Shujie Wang, et al.
Pharmacological Research (2023) Vol. 194, pp. 106846-106846
Open Access | Times Cited: 9
(+)-catechin protects PC12 cells against CORT-induced oxidative stress and pyroptosis through the pathways of PI3K/AKT and Nrf2/HO-1/NF-κB
Lai Chencen, Shuo Zhang, Zhiyu Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer’s Disease Treatment
Ying Song, Xinyi Zhu, Xiaomin Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9703-9703
Open Access | Times Cited: 15
A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy
Jinpeng Wang, Yuechen Wang, Fenfang Yang, et al.
ACS Chemical Biology (2024) Vol. 19, Iss. 5, pp. 1161-1168
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top